Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Monari

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 1994
Changes in purine nucleotide content in the lymphocyte subpopulations of patients infected with HIVA Tabucchi, F Carlucci, E Consolmagno, et al.
AIDS (London, England)|August 1, 1993
Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in cultureM C Re, G Zauli, D Gibellini, et al.
European Neurology|January 1, 1993
Retinal periphlebitis in multiple sclerosis: a marker of disease activity?M R Tola, E Granieri, I Casetta, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenzM C Re, P Monari, I Bon, et al.
Journal of Investigational Allergology & Clinical Immunology|January 6, 2016
Burden of Skin Disease in Selective IgA Deficiency and Common Variable ImmunodeficiencyG Gualdi, V Lougaris, M Baronio, et al.
The New Microbiologica|October 1, 1993
Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivityM C Re, G Furlini, E Ramazzotti, et al.
Blood|April 18, 1998
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. envelope-associated HLA class II molecules reverse this effectC Casoli, M C Re, P Monari, et al.
Dermatology Online Journal|December 10, 2013
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to AnakinraM Cattalini, A Meini, P Monari, et al.
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cellsM C Re, P Monari, D Gibellini, et al.
Microbiologica|October 1, 1992
Absence of HTLV-I/II infection in blood donors with positive and inconclusive HTLV-I/II serologyM C Re, G Furlini, E Ramazzotti, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 1994
Changes in purine nucleotide content in the lymphocyte subpopulations of patients infected with HIVA Tabucchi, F Carlucci, E Consolmagno, et al.
AIDS (London, England)|August 1, 1993
Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in cultureM C Re, G Zauli, D Gibellini, et al.
European Neurology|January 1, 1993
Retinal periphlebitis in multiple sclerosis: a marker of disease activity?M R Tola, E Granieri, I Casetta, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenzM C Re, P Monari, I Bon, et al.
Journal of Investigational Allergology & Clinical Immunology|January 6, 2016
Burden of Skin Disease in Selective IgA Deficiency and Common Variable ImmunodeficiencyG Gualdi, V Lougaris, M Baronio, et al.
The New Microbiologica|October 1, 1993
Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivityM C Re, G Furlini, E Ramazzotti, et al.
Blood|April 18, 1998
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. envelope-associated HLA class II molecules reverse this effectC Casoli, M C Re, P Monari, et al.
Dermatology Online Journal|December 10, 2013
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to AnakinraM Cattalini, A Meini, P Monari, et al.
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cellsM C Re, P Monari, D Gibellini, et al.
Microbiologica|October 1, 1992
Absence of HTLV-I/II infection in blood donors with positive and inconclusive HTLV-I/II serologyM C Re, G Furlini, E Ramazzotti, et al.
Pageof 6